This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
14 Nov 2014

Results Healthcare and Harel Consulting sign Cooperation Agreement to Facilitate Licensing in Emerging Markets

Results Healthcare, a healthcare advisory specialist that is part of the Results International Group, and Harel Consulting, a US-based business development consultancy with proprietary ties to leading pharmaceutical companies across the emerging markets, have signed a Cooperation Agreement.



According to the terms of the agreement, Results Healthcare will leverage its knowledge and relationships in the pharmaceutical and medical device sectors, particularly in Europe, to assist in identifying innovative companies that may become licensors for Harel Consulting’s Emerging Markets clients. Once the licensors are identified, the two companies may also work together to consummate the licensing deals.



Harel Consulting is led by Jacob Harel, a seasoned pharmaceutical executive with over 25 years of experience in the industry. Prior to founding Harel Consulting, he most recently served as Head of Corporate Business Development at Merck & Co., during which time he structured and negotiated a variety of deals around the globe and especially in Emerging Markets.



Kevin Bottomley, Managing Director at Results Healthcare commented on the agreement: “We are very pleased to have this opportunity to work with Harel Consulting. Jacob’s background enables him to see Emerging Markets opportunities from a developed world perspective. We believe that together we are well positioned to find the right opportunities for our clients in these markets.”



Jacob Harel, founder of Harel Consulting added: “Results Healthcare has an outstanding reputation for its knowledge and expertise in the pharmaceutical and medical devices sectors. Results Healthcare is well-suited to help us find, facilitate and execute licensing deals for our clients in Latin America, Eastern Europe, Middle East, Asia Pacific and Africa.  We look forward to a fruitful collaboration.”



These future licensing deals are expected to bring more therapeutic choices to millions of patients in the Emerging Markets. Results Healthcare and Harel Consulting indicated that they are proud to make a contribution to the improvement of patients' health in these markets.

Related News